Please login to the form below

Not currently logged in
Email:
Password:

Dihon

This page shows the latest Dihon news and features for those working in and with pharma, biotech and healthcare.

Bayer puts research at heart of business growth

Bayer puts research at heart of business growth

This area has been boosted over the past year with the acquisition of Merck &Co's consumer health division and the takeover of China-based Dihon Pharmaceutical.

Latest news

  • Bayer completes takeover of Chinese OTC company Bayer completes takeover of Chinese OTC company

    The company reported revenues of 123m for 2013 with sales mainly coming in Dihon's home market of China. ... Dihon also has a reach in some emerging markets in Asia and Africa, including NIgera, Vietnam and Cambodia.

  • Pharma is turning its attention to consumer healthcare Pharma is turning its attention to consumer healthcare

    The company also bought Chinese based Dihon Pharmaceuticals, which specialises in OTC medicines and traditional herbal remedies, to increase its offering and presence in Asia.

  • Bayer raises sales predictions for new pharma products Bayer raises sales predictions for new pharma products

    Fresh from announcing a deal to buy Chinese over-the-counter drugmaker Dihon Pharmaceutical, Bayer also reported a 4 per cent sales decline for its consumer health division to 1.96bn - ... Consumer health should return to low- to mid-single-digit growth

  • Bayer buys Chinese consumer care company Bayer buys Chinese consumer care company

    Acquires Dihon Pharmaceutical as Algeta takeover closes.  . Bayer has boosted its consumer healthcare operations in emerging markets with a deal to acquire China-based Dihon Pharmaceutical Group. ... According to its website, Dihon employs more than 2,

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Sustainable solutions Sustainable solutions

    This was followed five months later by the smaller, but still notable, deal to acquire the Chinese consumer healthcare company Dihon Pharmaceutical for around $485m.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics